| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/31/2003 | US20030143207 Remodeling of tissues and organ |
| 07/31/2003 | US20030143197 Administering to the animal omega interferon (IFN) at a dosage and activity for the disease state treated sufficient to induce a therapeutic response in the animal |
| 07/31/2003 | CA2514088A1 Use of cholinesterase antagonists to treat insulin resistance |
| 07/31/2003 | CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar |
| 07/31/2003 | CA2474292A1 Sustained release pharmaceutical composition |
| 07/31/2003 | CA2473829A1 Use of tgf-.beta. antagonists to treat or to prevent chronic transplant rejection |
| 07/31/2003 | CA2473796A1 Substituted quinazolin-4-ylamine analogues |
| 07/31/2003 | CA2473781A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | CA2473490A1 Peptide-carrying bodies for immune response |
| 07/31/2003 | CA2473395A1 Phospholipid bodies and use thereof in medical treatment |
| 07/31/2003 | CA2473392A1 5-ht3 receptor antagonists and methods of use |
| 07/31/2003 | CA2473386A1 Method |
| 07/31/2003 | CA2473032A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 07/31/2003 | CA2472835A1 Fused bicyclic pyrimidine derivatives |
| 07/31/2003 | CA2471740A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/31/2003 | CA2471383A1 Amido macrolides |
| 07/31/2003 | CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/31/2003 | CA2470185A1 Use of alkylphosphocholines in the prevention of protozoal diseases |
| 07/30/2003 | EP1331271A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 07/30/2003 | EP1330535A2 Kini-3 motor protein and methods for its use |
| 07/30/2003 | EP1330455A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 07/30/2003 | EP1330451A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/30/2003 | EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 07/30/2003 | EP1330442A1 Phthalazinone derivatives |
| 07/30/2003 | EP1330430A2 Integrin receptor inhibitors |
| 07/30/2003 | EP1330268A1 Targeted therapeutic agents |
| 07/30/2003 | EP1330262A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 07/30/2003 | EP1330249A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 07/30/2003 | EP1233960B1 Polymorphic salt of an anti-migraine drug |
| 07/30/2003 | EP1187817B1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/30/2003 | EP1056442B1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
| 07/30/2003 | EP0946541B1 Quinolines and their therapeutic use |
| 07/30/2003 | EP0910376B1 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 07/30/2003 | CN1433427A 依匹乐酮晶型 Epinastine music one polymorph |
| 07/30/2003 | CN1433424A 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 07/30/2003 | CN1433416A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamideinhibitors of cyclin dependent kinases |
| 07/30/2003 | CN1433415A N-[5-[[[5-alkyl-2-oxazlyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 07/30/2003 | CN1433414A Benzazole derivatives and their use as JNK modulators |
| 07/30/2003 | CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/30/2003 | CN1433411A Chemical compounds |
| 07/30/2003 | CN1433408A Aminothiazole inhibitors of cyslin dependent kinases |
| 07/30/2003 | CN1433407A Bis-arylsulfones |
| 07/30/2003 | CN1433396A Pharmaceutical compounds |
| 07/30/2003 | CN1433319A Enzyme treatment for infection |
| 07/30/2003 | CN1433316A Biologically active agents and drugs |
| 07/30/2003 | CN1433313A Combination of serotonin reuptake inhibitor and 5-HT2C antagonist, inverse agonist or partial agonist |
| 07/30/2003 | CN1432404A Honeysuckle-glossy ganoderma tea and its prepn process |
| 07/30/2003 | CN1432402A Meridian passage dredging glossy ganoderma wine |
| 07/30/2003 | CN1432400A Glossy ganoderma health wine |
| 07/30/2003 | CN1432395A Chinese medicine prepn for relaxing bowels |
| 07/30/2003 | CN1432394A Medicine for treating stomach trouble |
| 07/30/2003 | CN1432388A Sheep fetus peptide oral liquid and its prepn |
| 07/30/2003 | CN1432387A Honeyed pill for dredging meridian passage, eliminating phlegm and expelling toxin and its prepn process |
| 07/30/2003 | CN1432385A Hepatitis B treating medicine pill |
| 07/30/2003 | CN1432374A Kidney asthenia treating medicine and its prepn process |
| 07/30/2003 | CN1432366A Use of mica in preparing medicine |
| 07/30/2003 | CN1432289A Ginseng flower health tea and its producing process |
| 07/30/2003 | CN1116293C Preparation of dihydromyricetrin |
| 07/30/2003 | CN1116291C Substituted tetracyclic tetrahydrofuran derivatives |
| 07/30/2003 | CN1116074C Buccal lozenge for preventing dental caries and its production method |
| 07/30/2003 | CN1116069C Health oral liquid for old people and preparation process thereof |
| 07/30/2003 | CN1116063C Chinese medicine for nourishing yin and treating constipation |
| 07/30/2003 | CN1116059C Shenxian capsule |
| 07/30/2003 | CN1116053C Liver protecting and pus drawing out ointment and its preparation |
| 07/30/2003 | CN1116047C Functional food for protecting liver and medicine for preventing and ucring hepatitides prepared from loach and its preparing process |
| 07/29/2003 | US6600038 Carbamoyl tetrahydropyridine derivatives |
| 07/29/2003 | US6600032 Compound for use in the treatment of viral, protozoan and parasitic infections |
| 07/29/2003 | US6599925 Cardiovascular disorders; anticancer agents |
| 07/29/2003 | US6599910 Substituted triazole compounds |
| 07/29/2003 | US6599908 Fused polycyclic 2-aminopyrimidine derivatives |
| 07/29/2003 | US6599900 1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones |
| 07/29/2003 | US6599890 Inhibitors of matrix metalloproteinases or the production of tumor necrosis factor |
| 07/29/2003 | US6599879 Therapeutic uses of keratinocyte growth factor-2 |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599498 Enhanced magnetic resonance imaging agent and a hematinic agent; carboxyalkylated reduced polysaccharides coated ultrasmall superparamagnetic iron oxides; carboxymethyl reduced dextran as a plasma extender |
| 07/29/2003 | CA2244621C 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists |
| 07/29/2003 | CA2185036C Use of a non photosynthetic filamentous bacteria extract and composition containing the same |
| 07/29/2003 | CA2078379C Method of treating immunoinflammatory disease |
| 07/29/2003 | CA2066332C Substituted 3-(pyridinylamino)-indoles and benzo¬b|thiophenes, a process for their preparation and their use as medicaments |
| 07/24/2003 | WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060091A2 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003059950A1 Ifnar2 mutants, their production and use |
| 07/24/2003 | WO2003059939A1 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds |
| 07/24/2003 | WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 07/24/2003 | WO2003059921A1 Mmp inhibitors |
| 07/24/2003 | WO2003059906A1 Prucalopride-n-oxide |
| 07/24/2003 | WO2003059905A1 Pyrrolidone carboxamides |
| 07/24/2003 | WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059886A1 Acyl sulfonamide derivative |
| 07/24/2003 | WO2003059884A1 Modulators of lxr |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059874A2 Aromatic thioether liver x-receptor modulators |
| 07/24/2003 | WO2003059873A1 Potassium channel modulators |
| 07/24/2003 | WO2003059871A1 N-alkylsulfonyl-substituted amide derivatives |
| 07/24/2003 | WO2003059393A1 Pantoprazole cyclodextrin inclusion complexes |
| 07/24/2003 | WO2003059359A1 D-tagatose as an anti-biofilm agent |